共 63 条
- [1] Hugli T.E., Muller Eberhard H.J., Anaphylatoxins: C3a and C5a, Adv. Immunol., 26, pp. 1-53, (1978)
- [2] Ward P.A., Newman L.J., A neutrophil chemotactic factor from human C’5, J. Immunol., 102, pp. 93-99, (1969)
- [3] Henson P.M., The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles, J. Immunol., 107, pp. 1535-1546, (1971)
- [4] Goetzl E.G., Austen K.F., Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors, J. Clin. Invest., 53, pp. 591-599, (1974)
- [5] Wardlaw A.J., Moqbel R., Cromwell O., Kay A.B., Platelet-activating factor: A potent chemotactic and chemoki-netic factor for human eosinophils, J. Clin. Invest., 78, pp. 1701-1706, (1986)
- [6] Morita E., Schroder J.-M., Christophers E., Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins, Scand. J. Immunol., 29, pp. 709-716, (1989)
- [7] Altman L.C., Hill J.S., Hairfield W.H., Mullarkey M.F., Effects of corticosteroids on eosinophil chemotaxis and adherence, J. Clin. Invest., 67, pp. 28-36, (1981)
- [8] Bruijnzeel P.L.B., Kuijper P.H.M., Rihs S., Betz S., Warringa R.A.J., Koenderman L., Eosinophil migration in atopic dermatitis. I. Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4, J. Invest. Dermatol., 100, pp. 137-142, (1993)
- [9] Morita E., Schroder J.-M., Christophers E., Chemotactic responsiveness of eosinophils isolated from patients with inflammatory skin diseases, J. Dermatol., 16, pp. 348-351, (1989)
- [10] Warringa R.A.J., Mengelers H.J.J., Kuijper P.H.M., Raaijmakers J.A.M., Bruijnzeel P.L.B., Koenderman L., In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals, Blood, 79, pp. 1836-1841, (1992)